Rhabdomyolysis and drugs of abuse

Journal of Emergency Medicine

Volumn 19, Issue 1, 2000, Pages 51-56

  Richards, John R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Cocaine; Drug abuse; Ethanol; Heroin; Rhabdomyolysis

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; COCAINE; CREATINE KINASE; DIAMORPHINE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; MYOGLOBIN; PHENCYCLIDINE; PHOSPHATE; POTASSIUM; PURINE DERIVATIVE;

ACUTE KIDNEY FAILURE; DRUG ABUSE; HUMAN; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SEPSIS; SMOKING; TOBACCO; URINALYSIS;

EID: 0034237466     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(00)00180-3     Document Type: Article

References (62)

1. Knochel J.P. Mechanisms of rhabdomyolysis. Curr Opin Rheum. 5:1993;725-731.
2. The Bible. Numbers 11:31-35.
3. Bywaters E.G.L., Beall D. Crush injuries with impairment of renal function. Br Med J. 1:1941;427-432.
4. Gabow P.A., Kaehny W.D., Kelleher S.D. The spectrum of rhabdomyolysis. Medicine. 61:1982;141-152.
5. Cadnapaphornachai P., Taher S., McDonald F.D. Acute drug-associated rhabdomyolysis An examination of its diverse renal manifestations and complications . Am J Med Sci. 280:1980;66-72.
6. Spector R., Choudhury A., Cancilla P., et al. Alcohol myopathy. JAMA. 242:1979;1648-1649.
7. Poels P.J.E., Gabreels F.J.M. Rhabdomyolysis a review of the literature . Clin Neurol and Neurosurg. 95:1993;175-192.
8. Pravin C.S., Mirel A., Jayanti V. Rhabdomyolysis in the hyperosmolar state. Am J Med. 88:1990;9-12.
9. Curry S.C., Chang D., Connor D. Drug and toxin-induced rhabdomyolysis. Ann Emerg Med. 18:1989;1068-1084.
10. 131I-labeled myoglobin in human beings. Clin Chem Acta. 17:1967;339-347.
11. Ward M.M. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 148:1988;1553-1557.
12. Veenstra J., Smit W.M., Krediet R.T., Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant. 9:1994;637-641.
13. Meroney W.H., Arney G.K., Segar W.E., et al. The acute calcification of traumatized muscle, with particular reference to post-traumatic renal insufficiency. J Clin Invest. 36:1957;825-832.
14. Koffler A., Freidler R.M., Massry S.G. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med. 85:1976;23-28.
15. Knochel J.P., Schlein E. On the mechanism of rhabdomyolysis in potassium depletion. J Clin Invest. 51:1972;1750-1758.
16. Knochel J.P., Dotin L.N., Hamburger R.J. Heat stress, exercise, and muscle injury effects on urate metabolism and renal function . Ann Intern Med. 81:1974;321-328.
17. Chesson A.L., Kasarskis E.J., Small V.W. Postictal elevation of serum creatine kinase level. Arch Neurol. 40:1983;315-317.
18. Ginsberg M.D., Hertzman M., Schmidt-Nowara W.W. Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann Intern Med. 73:1970;81-85.
19. Bunn H.F., Jandl J.H. Exchange of heme among hemoglobin molecules. Proc Natl Acad Sci USA. 56:1966;974-978.
20. Eneas J.F., Schoenfeld P.Y., Humphreys M.H. The effect of infusion of mannitol-bicarbonate on the clinical course of myoglobinuria. Arch Intern Med. 139:1979;801-805.
21. Ron D., Taitelman U., Michaelson M., et al. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med. 144:1984;277-280.
22. Finley J., VanBeek A., Glover J.L. Myonecrosis complicating carbon monoxide poisoning. J Trauma. 17:1977;536-540.
23. Coburn R.F. The carbon monoxide body stores. Ann NY Acad Sci. 174:1970;11-22.
24. Haller R.G., Knochel J.P. Skeletal muscle disease in alcoholism. Med Clin North Am. 68:1984;91-103.
25. Song S.K., Rubin E. Ethanol produces muscle damage in human volunteers. Science. 175:1972;327-328.
26. Bessa O. Alcoholic rhabdomyolysis a review . Conn Med. 59:1995;519-520.
27. Anderson R., Cohen M., Haller R., et al. Skeletal muscle phosphorus and magnesium deficiency in alcoholic myopathy. Miner Electrolyte Metab. 6:1980;106-112.
28. Richter R.W., Challenor Y.B., Pearson J., et al. Acute myoglobinuria associated with heroin addiction. JAMA. 216:1971;1172-1176.
29. Simon E.J. The effects of narcotics on cells in tissue culture. Clouet D., Narcotic drugs biochemical pharmacology . 1971;248-259 Planum Press, New York.
30. D'Agostino R.S., Arnett E.N. Acute myoglobinuria and heroin snorting. JAMA. 241:1979;277.
31. Counselman F.L., McLaughlin E.W., Kardon E.M., Bhambhani-Bhavnani A.S. Creatine phosphokinase elevation in patients presenting to the emergency department with cocaine-related complaints. Am J Emerg Med. 15:1997;221-223.
32. Welch R.D., Todd K., Krause G.S. Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med. 20:1991;154-157.
33. Pagala M., Amaladevi B., Azad D., et al. Effect of cocaine on leakage of creatine kinase from isolated fast and slow muscles of rat. Life Sci. 52:1993;751-756.
34. Brody S.L., Wrenn K.D., Wilber M.W., et al. Predicting the severity of cocaine-associated rhabdomyolysis. Ann Emerg Med. 19:1990;1137-1143.
35. Daras M., Kakkouras L., Tuchman A.J., Koppel B.S. Rhabdomyolysis and hyperthermia after cocaine abuse a variant of the neuroleptic malignant syndrome? Acta Neurol Scanda. 92:1995;161-165.
36. Cappon G.D., Morford L.L., Vorhees C.V. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res. 103:1997;155-162.
37. Marshall J.F., O'Dell S.J., Weimuller F.B. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J Neur Transm. 91:1993;241-254.
38. Zalis E.G., Parmley L.F. Fatal amphetamine poisoning. Arch Intern Med. 112:1963;822-826.
39. Kendrick W.C., Hull A.R., Knochel J.P. Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med. 86:1977;381-387.
40. Lehmann E.D., Thom C.H., Croft D.N. Delayed severe rhabdomyolysis after taking "ectasy" Postgrad Med J. 71:1995;186-187.
41. Scandling J., Spital A. Amphetamine-associated myoglobinuric renal failure. South Med J. 75:1982;237-240.
42. Ellinwood E. Assault and homicide associated with amphetamine abuse. Am J Psychiatry. 127:1971;90-95.
43. Richards J.R., Derlet R.W., Duncan D.R. Methamphetamine toxicity treatment with a benzodiazepine versus a butyrophenone . Eur J Emerg Med. 4:1997;130-135.
44. Sperling LS, Horowitz JL. Methamphetamine-induced choreoathetosis and rhabdomyolysis. Ann Int Med 121:986.
45. Weis J. On the hyperthermic response to D-amphetamine in the decapitated rat. Life Sci. 13:1973;475-484.
46. Zalis E.G., Kaplan G., Lundberg G.D. Acute lethality of amphetamines in dogs and its antagonism by curare. Proc Soc Exp Biol Med. 118:1965;557-561.
47. Morgan P., Beck J.E. The legacy and the paradox hidden contexts of methamphetamine use in the United States . Klee H., Amphetamine misuse international perspectives on current trends . 1997;135-162 Harwood Publishers, Amsterdam.
48. Kupfer D.J., Meltzer H.Y., Wyatt R.J. Serum enzyme changes during sleep deprivation. Nature. 228:1970;768-770.
49. Segal D.S., Kuczenski R. Repeated binge exposures to amphetamine and methamphetamine behavioral and neurochemical characterization . J Pharm Exp Ther. 282:1997;561-573.
50. Stephans S., Yamamoto B. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 700:1995;99-106.
51. Wilson J., Kalasinsky K., Levey A., et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med. 2:1996;699-703.
52. Iyo M., Namba H., Yanagisawa M., Hirai S., Yui N., Fukui S. Abnormal cerebral perfusion in chronic methamphetamine abusers a study using 99MTc-HMPAO and SPECT . Prog Neuro-Psychopharm Biol Psych. 21:1997;789-796.
53. Fleckenstein A.E., Metzger R.R., Wilkins D.G., et al. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharm Exp Ther. 282:1997;834-838.
54. Villemagne V., Yuan J., Wong D.F., et al. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans evidence from [C-11]WIN-35,428 positron emission tomography studies . J Neurosci. 18:1998;419-427.
55. Rhee K., Alberton T.E., Douglas J. Choreoathetoid disorder associated with amphetamine-like drugs. Am J Emerg Med. 6:1988;131-133.
56. Cogen F.C., Rigg G., Simmons J.L., Domino E.F. Phencyclidine-associated acute rhabdomyolysis. Ann Intern Med. 88:1978;210-212.
57. Kuncl R.W., Meltzer H.Y. Pathologic effect of phencyclidine and restraint on rat skeletal muscle prevention by prior denervation . Exp Neurol. 45:1974;387-402.
58. Koff R.S., Widrich W.C., Robbins A.H. Necrotizing angiitis in a methamphetamine user with hepatitis Bangiographic diagnosis, five month follow up results and localization of bleeding site. N Engl J Med. 288:1973;946-948.
59. Brooks G.F., O'Donoghue J.M., Rissing J.P., et al. Eikenella corrodens, a recently discovered pathogen infections in medical-surgical patients and in association with methylphenidate abuse . Medicine. 53:1974;325-342.
60. Tuazon C.U., Hill R., Sheagren J.N. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis. 129:1974;327-329.
61. Christin L., Sarosi G. Pyomyositis in North America case reports and review . Clin Infect Dis. 15:1992;668-677.
62. Tracey K., Lowry S., Beutler B., et al. Cachectin/TNF mediates changes of skeletal muscle plasma membrane potential. J Exp Med. 164:1986;1368-1373.